Intravitreal devices for the treatment of vitreous inflammation.
about
Ocular delivery of macromoleculesFunctionalization of ethylene vinyl acetate with antimicrobial chlorhexidine hexametaphosphate nanoparticles.A sustained intravitreal drug delivery system with remote real time monitoring capability.Drug delivery implants in the treatment of vitreous inflammationTreatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.Principles of pharmacology in the eye.Ocular delivery of proteins and peptides: challenges and novel formulation approaches.
P2860
Q34079676-3B1B1F95-7CC9-468C-BA42-FE0B50CEDD40Q34148982-07451DB3-F5BF-42DF-A753-6E81ACC1C095Q36029456-8C038690-0E4C-4B10-9FE8-0FCE4D07A141Q38160003-C6452526-05BF-476B-91FF-8ED7B53E4130Q39136236-49FBC1E6-CCE4-40C5-B1DE-F6CDA17D3B99Q45871474-181D21F3-2A5D-4512-A188-CB194D92EEBBQ47729137-0D327637-E907-495D-B723-913CCA100DFF
P2860
Intravitreal devices for the treatment of vitreous inflammation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Intravitreal devices for the treatment of vitreous inflammation.
@en
type
label
Intravitreal devices for the treatment of vitreous inflammation.
@en
prefLabel
Intravitreal devices for the treatment of vitreous inflammation.
@en
P2093
P2860
P356
P1476
Intravitreal devices for the treatment of vitreous inflammation.
@en
P2093
Angela Jiang
Jillian Wang
John B Christoforidis
Susie Chang
P2860
P304
P356
10.1155/2012/126463
P577
2012-09-05T00:00:00Z